BioSpace News Archive

Exelead, Inc., a contract development and manufacturing company providing complex medicines to customers and their patients, delivered its first vaccine precursor batch manufactured at its facility, as part of an agreement with Pfizer for the Pfizer-BioNTech COVID-19 Vaccine.

Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”) announced today that the U.S. Food & Drug Administration (FDA) has approved Ryplazim®

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to Beau Standish and 44 non-executive employees in connection with the closing of its acquisition of 7D Surgical.

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the companies will host a virtual investor event on Monday, June 7, 2021 at 6 p.m. Eastern Time to discuss toripalimab clinical data from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.

Alpine Immune Sciences, Inc. announced presentation of initial data from NEON-1, the company’s Phase 1 clinical trial of ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor, at the American Society of Clinical Oncology (ASCO) Virtual Annual Meeting.

AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 17, 2021.

Centessa Pharmaceuticals plc (“Centessa”), a clinical-stage company employing its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines to patients, announced today that, in connection with its previously announced initial public offering of 16,500,000 American Depositary Shares (“ADSs”).

- Liminal BioSciences Inc. announced the voting results from its Annual General and Special Meeting of Shareholders held virtually on June 4, 2021 .

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference at 4:40 p.m. ET on Wednesday , June 9, 2021.

Calgary-based biotechnology company launches on-site laboratory to provide rapid PCR COVID-19 testing with results within four hours: